Methodist Le Bonheur expands monoclonal antibody therapies

Published: Oct. 6, 2021 at 5:39 AM CDT
Email This Link
Share on Pinterest
Share on LinkedIn

MEMPHIS, Tenn. (WMC) - Methodist Le Bonheur Healthcare is expanding its monoclonal antibody therapies for COVID-19 patients.

Methodist is the first organization in Tennessee to join this national initiative sponsored by the U.S. Department of Health and Human Services.

The goal is to help end COVID-19 and improve health equity in under-served communities.

There are two infusion locations: Methodist University Hospital and the Methodist Monoclonal Infusion Center on Hacks Cross.

Copyright 2021 WMC. All rights reserved.

Click here to sign up for our newsletter!

Click here to report a spelling or grammar error. Please include the headline.